Connor, Clark & Lunn Investment Management (CC&L)’s Voyager Therapeutics VYGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-24,673
| Closed | -$230K | – | 1719 |
|
|
2024
Q1 | $230K | Buy |
+24,673
| New | +$230K | ﹤0.01% | 1360 |
|
|
2023
Q4 | – | Sell |
-36,425
| Closed | -$282K | – | 1579 |
|
|
2023
Q3 | $282K | Sell |
36,425
-74,584
| -67% | -$578K | ﹤0.01% | 1158 |
|
|
2023
Q2 | $1.27M | Buy |
111,009
+191
| +0.2% | +$2.19K | 0.01% | 725 |
|
|
2023
Q1 | $854K | Sell |
110,818
-5,587
| -5% | -$43.1K | ﹤0.01% | 755 |
|
|
2022
Q4 | $710K | Buy |
116,405
+4,250
| +4% | +$25.9K | ﹤0.01% | 789 |
|
|
2022
Q3 | $664K | Sell |
112,155
-8,076
| -7% | -$47.8K | ﹤0.01% | 752 |
|
|
2022
Q2 | $711K | Sell |
120,231
-13,341
| -10% | -$78.9K | ﹤0.01% | 696 |
|
|
2022
Q1 | $1.02M | Sell |
133,572
-13,962
| -9% | -$106K | 0.01% | 658 |
|
|
2021
Q4 | $400K | Buy |
147,534
+115,404
| +359% | +$313K | ﹤0.01% | 841 |
|
|
2021
Q3 | $85K | Buy |
+32,130
| New | +$85K | ﹤0.01% | 991 |
|
|
2020
Q2 | – | Sell |
-26,400
| Closed | -$242K | – | 1186 |
|
|
2020
Q1 | $242K | Buy |
26,400
+2,637
| +11% | +$24.2K | ﹤0.01% | 837 |
|
|
2019
Q4 | $331K | Buy |
+23,763
| New | +$331K | ﹤0.01% | 743 |
|